Loading ...

erythrocyte membrane-camouflaged poly(lactic-co-glycolic acid) nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

carboxy-terminated poly(lactic-co-glycolic acid)

carboxy-terminated PLGA
Type Polymer
Formula
Role core
2

red blood cell membrane

RBC membrane RBCm
Type Bioobject
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
stability

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information/entries available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

erythrocyte membrane-camouflaged poly(lactic-co-glycolic acid) nanoparticles

Hydrodynamic diameter: ~ 85 nm

Medium: phosphate buffer solution

Support: none

Method 2

Type: Chemical synthesis
Source:
Product

erythrocyte membrane-camouflaged poly(lactic-co-glycolic acid) nanoparticles

Diameter: ~ 70 nm

Size: ~ 80 nm

Thickness: 7 - 8 nm

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Product

erythrocyte membrane-camouflaged poly(lactic-co-glycolic acid) nanoparticles

Radius: 35 nm

Size: 85 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial